logo

For the Inventor, By the Inventor

Hafnarfjordur, Iceland

Actavis Group Ptc Ehf


USPTO Granted Patents = 13

% Expired Patents = 69.2


Trademarks = 1

Forward Citations = 51

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Nitin Sharadchandra Pradhan (11 out of 11 patents)

silverMedal Jon Valgeirsson (6 out of 6 patents)

bronzeMedal Girish Dixit (5 out of 5 patents)

4.  Mayur Devjibhai Khunt (4 out of 4 patents)

5.  Krishnadatt Sharma (4 out of 4 patents)

6.  Sandipan Prabhurao Bondge (3 out of 3 patents)

7.  Vikas Daulatrao Ahirao (3 out of 3 patents)

8.  Kundan Singh Shekhawat (3 out of 3 patents)

9.  Anil Shahaji Khile (2 out of 2 patents)

10.  Jayesh Laljibhai Patel (2 out of 2 patents)

11.  Richard Anthony Flynn (1 out of 1 patent)

12.  Rahul Surana (1 out of 9 patents)

13.  Anil Chhettry (1 out of 8 patents)

14.  David Farrington (1 out of 1 patent)

15.  Ritesh Sanghvi (1 out of 5 patents)


13 patents:

1. 10441536 - Micronized colistimethane sodium pharmaceutical compositions (2019-10-15),
2. 9512060 - Solid state forms of tapentadol salts (2016-12-06),
3. 9006443 - Process for preparing quinoline-3-carboxamide derivatives (2015-04-14),
4. 8981154 - Solid state forms of tapentadol salts (2015-03-17),
5. 8859769 - Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine (2014-10-14),
6. 8552194 - Process for preparing quinoline-3-carboxamide derivatives (2013-10-08),
7. 8354428 - Solid state forms of laquinimod and its sodium salt (2013-01-15),
8. 8314235 - Process for preparing varenicline, varenicline intermediates, pharmaceutically acceptable salts thereof (2012-11-20),
9. 8288592 - Solid state forms of tapentadol salts (2012-10-16),
10. 8101769 - Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide (2012-01-24),
11. 8101597 - Quetiapine salts and their polymorphs (2012-01-24),
12. 8071767 - Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one hydrochloride (2011-12-06),
13. 7947699 - Anhydrous amorphous imatinib mesylate (2011-05-24),
Company Overview
Actavis Group Ptc Ehf is a global pharmaceutical company headquartered in Hafnarfjordur, Iceland. The organization specializes in the development, manufacturing, and distribution of generic and specialty pharmaceuticals. Actavis is committed to enhancing patient access to high-quality medications across various therapeutic areas, including central nervous system, cardiovascular, and infectious diseases. With a focus on innovation and efficiency, the company leverages advanced technologies to improve drug formulation and delivery, ensuring compliance with international standards.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#1 in Hafnarfjordur

#7 in Iceland

#45,039 in the World

Hafnarfjordur, IS
Hafnarfjordur, Iceland

Actavis Group Ptc Ehf

Forward Citations = 51

25 inventors:

goldMedal Nitin Sharadchandra Pradhan (11 out of 11 patents)

silverMedal Jon Valgeirsson (6 out of 6 patents)

bronzeMedal Girish Dixit (5 out of 5 patents)

4.  Mayur Devjibhai Khunt (4 out of 4 patents)

5.  Krishnadatt Sharma (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Actavis Group Ptc Ehf. Retrieved from https://idiyas.com/company/actavis-group-ptc-ehf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…